Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sorin CE marks self-anchoring aortic heart valve

This article was originally published in Clinica

Executive Summary

Sorin (Milan, Italy) has CE marked its Perceval S aortic heart valve for sale in Europe. The self-anchoring biological valve is indicated for the minimally-invasive surgical replacement of the aortic valve in patients with aortic stenosis. Around 3% of 75-year-old patients have severe symptomatic aortic stenosis and if the disorder is untreated, the average survival is only two to three years. The Perceval S is made of bovine pericardium and is mounted on a super-elastic alloy frame.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT096640

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel